CYP1B1-AS1 Delays the Malignant Progression of Colorectal Cancer by Binding with NOP58.

Zhao WuFei ChengLebin YuanXiaodong LiZhigang LiZeyu HuangShengping MaoXing ChenJiwei WangBin LaiWei Shen

Published in: Digestive diseases and sciences (2023)

This research proves that CYP1B1-AS1 can inhibit the occurrence of EMT in CRC by binding with NOP58, thus delaying the progress of CRC. This finding indicates that CYP1B1-AS1 may be a novel biomarker to improve the diagnosis and treatment of CRC.

Keyphrases

risk assessment
epithelial mesenchymal transition
dna binding
binding protein
transcription factor